SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: phoenix_rising who wrote (1536)10/16/2015 11:24:47 AM
From: Mirror Image  Read Replies (1) of 2026
 
Wonder what the average price they paid for them was....

That would be hard to know exactly - but it's easy to figure out the share price range for the quarter.

3Q 2015: Apricus High: $1.99 Apricus Low: $1.10

Better yet, if I'm not mistaken, Vanguard bought these shares in the last month of the Quarter - September. I know this because they update their holding Monthly. And the majority of the increase happened in September.

September 2015: Apricus High: $1.99 Low: $1.41

Only two high Volume days in September - September 1st and September 10 - both of which - had Apricus trading at the high of that range. It doesn't mean they bought those shares for sure on those days but it is obviously easier for them to acquire shares on a High Volume day rather than your normal 100k shares traded day.

Total Shares traded in September 2015: 7,076,600

*- The two previously mentioned days in the month of September almost add up to 3 M shares traded.

Just for future reference I will list the total volume for each month of this year:

January 2015: 8,946,800
February 2015: 12,659,200
March 2015: 6,630,100

Apricus issued shares to Sarissa Capital and Bank Julius Baer during this quarter.

April 2015: 2,498,400
May 2015: 2,630,800
June 2015: 1,817,300

187,187 shares added to Institutions from Retail Investors during this quarter. Apricus did not issue any shares this quarter to any Institution ( Aspire or Sarissa ). No argument can be made that the increase in Institutional shares was due to issuance of new shares directly from the company.

July 2015: 3,250,900
August 2015: 5,801,000
September 2015: 7,076,600

Let's see what happens with the Institutional Ownership in Apricus this quarter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext